معرفی
Dr. Jinlong Ru is a Research Fellow at the Institute of Virology, Helmholtz Center Munich, Germany, where he leads research in phage therapy, metagenomics, and natural product drug discovery. His work develops advanced computational tools for viromic data analysis to elucidate phage-host interactions and accelerate therapeutic discovery, with strong ties to the Technical University of Munich where he completed his doctoral studies.
His academic qualifications include:
- Ph.D. in Bioinformatics, Technical University of Munich, Germany (2015-2023)
- M.Sc. in Bioinformatics, Northwest A&F University, China (2012-2015)
- B.Sc. in Biotechnology, Northwest A&F University, China (2008-2012)
Dr. Ru's research integrates computational biology with virology to pioneer phage-based therapeutics, focusing on metagenomic analysis of microbial ecosystems and natural product pipelines for antimicrobial discovery. His expertise spans machine learning applications in genomic data, phage ecology in environmental and clinical contexts, and translational development of viromic insights into novel treatments for antibiotic-resistant infections.
His recent publications reveal a trajectory toward interdisciplinary translational science, bridging structural genomics, microbiome dynamics, and clinical oncology. Key themes include machine learning-driven variant detection across species, urbanization's impact on microbiome-cancer links, and bacteriophage-mediated protection in transplantation medicine. This work demonstrates consistent innovation in computational frameworks applied to high-impact biomedical challenges.
As an active collaborator in international consortia, Dr. Ru contributes to projects advancing phage therapy through computational design, with emerging focus on personalized antimicrobial strategies and microbiome engineering for clinical applications.
